| Tag | Content |
|---|
EnhancerAtlas ID | HS164-07567 |
Organism | Homo sapiens |
Tissue/cell | Raji |
Coordinate | chr2:238659920-238661950 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NFKB1 | MA0105.4 | chr2:238661628-238661641 | GGGGGATTCCCCA | - | 6.13 | | NFKB1 | MA0105.4 | chr2:238661628-238661641 | GGGGGATTCCCCA | + | 6.14 | | REL | MA0101.1 | chr2:238661782-238661792 | GGGGATTTCC | + | 6.02 | | SOX10 | MA0442.2 | chr2:238661896-238661907 | TTCTTTGTTTT | - | 6.62 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_09199 | chr2:238660976-238662292 | CD14 | | SE_18373 | chr2:238660916-238662393 | CD4p_CD25-_Il17-_PMAstim_Th |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr2 | 238661415 | 238661733 | | chr2 | 238661867 | 238661942 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I237752 | chr2 | 238661068 | 238662094 |
|
Enhancer Sequence | ATTCACAGAC GTGTGGTCTC ACGATATTAA CCCAACTTAA CTTAAAAAAA AAAACAACAT 60
CCTAAAGAAG AAATTCAAAG TGCATGCTTA CTGTAAATAG GCTCCAGGGT GTAGAAGAAC 120
TCACAATGGC AGGAGTGCCG GCATGGGTGT ACACTCACCA TTTTCCCAAA TGCATTGTTT 180
GAACCAAGAT TGAAAATGTA ACTGCCCAGT AGAAAAGGTT ACTAACATAC TCCCTGATGC 240
ATGCCTTAGA CTTACCATCC TTCCCCCAGG CTTAAAACCA GTTTCTCATT TCCCATAGGC 300
GTGTGCCAGA CACTTGAAGA AGGTTCTTGG TTTTCTTCAC TTTTTGTAGT AGTTGTATAC 360
AAAAATGCTT CAGTTGATTT GCTTCTCAAA ATATCTGATG TCTACTAATA AGGCCGTCCT 420
CACATGCCAC ACTTTTGAAA CATCCCAATT ATTTGCACCC TGTAAAATGC TACTAATTGA 480
AGTAAAGACT GACTATGGCA TTGGCTTTCT TGGAGCGTGT GCACACTGCT TTTAGAGTGT 540
GCAGTGACTT CATTGCACCA GCCAGGAGAT GTGGTTGCCC TGTTCCTTGA CAGTAAGGTG 600
GGCAATCAGT GACTGTCTTC CTTAGGCAGC AGCGGATCAT GGATCTGGAA GTGGGTGGCG 660
TATCTGTTAC TTCCTTTTCA GCCCCCTAGA AAGTACCTGC AAGATCATTT GAATTTAATA 720
TCAAAGGGCA CCAGACAGAG GAGGTGACAT CGATCATGAC TAATTCACTA TCTTCATATC 780
TGCCACCTTT CCTGAAAGGG GGAAAAATAA GACTCTGGCT TTCAATTCAT GCGAAAAGGA 840
GCCACTTGGC CAGGCGTGGT GGCTCACGCC TGTAATTCCA CACTTTGGGA GGCCGAGGTG 900
GGTGGATCAC CGGAGGTCAG GAGTTTGAGA CCAGCCTGGC CAACATGGTG AGACCCCGTC 960
TCTACTAAAA ATATAAAAAT TAGCCAGGTG TGGTGGTGCG CACCTGTAAT CCCAGCTACT 1020
TGGGAGGCTG AGTCAGGAGA ATCACTTGAA CCTGGCAGGT GGAGGCTGCA GTGAGCCGAG 1080
ATCGTGCCAC TGCACTCCAG CCTGGGTGAC AGAGCGAGAC ACTGTTTCAA AAAAGAAAAA 1140
ATGCTGCTGG GGAGCCACTG AACCAACCGG AGACCCGCTG GTCCCACGTG AAGCAGCTGT 1200
CCTGGTGTGG AGGTACAGAG CTAGACCAGC ACTGGTCCCT CCAGCCCCCT GGTAGCCTCT 1260
GCTGCACCTG AACTGGCAGC TCTTGCCGCT GCCTTTAGCT CTGCATGTAT GCGCCCTGAA 1320
GGTTCTGCCT CTCTGTTTTG GAATCGCCTT CCCCTCCTCA TGTTTGGGGA CCTGCAAGGG 1380
TGTGAGGCAC GTGAGGGCAT CGCCATGCGT ATTTTACAGG CCTCTTTCTC TGGACTGTCC 1440
TTCAAAGGGA ATGACCTTTG TCTTTCCAGG ACCTACCCAG TGAGATCTGC CTGCCATTTT 1500
CCTATGAGTC AAAAATCTGA ACTCACTACT GCTCCTTTCC TGGTTCATAA GCCAGAGTAG 1560
GGCTGGTTGG CAGTCACTGG CTTGTGGCCC TATGTAATTA TCTCAGCCAT CACACACTGG 1620
CTCTTTCACA AGGGCTGGTC ACACGCCTCG AGTGATTCTT CAGAAATCTG TTGAACAGCC 1680
TGACACCCAG CCCTAGGACG CCGTGCTGGG GGGATTCCCC AGCTACTGAG TGGGGCCAGA 1740
GACTCTACTG CCTCTGTGAC CACATCCCTT TCCATACTGG TATCTCGTTT GTTCTAATGA 1800
GTGTGTCCAT TGCTTTTAAT AGTGAATTTT CTGAGCAATG AGAATTTGAC CAAATTGAAA 1860
AGGGGGATTT CCATGCATTT GAAATTGCCA TGTGTTTCTT CTTCTGATCC ATTTGCTCTA 1920
AGAAATATAG TCTAAGTTTA GGACTGAGGG TTTTTTTTTA ACAGAATACT GAATGATTCT 1980
TTGTTTTGAT TTTTTTATTG CAATTTCAAA AATATGACCT GCTTTCCACA 2030
|
